This means it can predict how the structure and arrangement of mRNA features influence the cell’s ability to make proteins. “Cells coordinate which mRNAs they produce and how efficiently they are ...

Yet not all large-scale research into mRNA vaccines in the United States is being dismantled. Nature has learnt that, even as ...

Japan biotech xFOREST Therapeutics is teaming up with a drug discovery solutions provider in a research pact aiming to ...

Axcelead--xFOREST Therapeutics Co., Ltd. (“xFOREST”) and Axcelead Drug Discovery Partners, Inc. (“Axcelead DDP”) today announced the launch of a joint research collaboration aimed at developing RNA ...

To solve a problem, scientists first need to see it clearly. Whether it’s a virus slipping past the immune system or plaques ...

Biotech company Factor Bioscience sued rival Cellectis and pharmaceutical giant AstraZeneca in Delaware federal court on ...

Breakthrough cancer vaccine Enteromix uses personalized mRNA technology for targeted treatment with minimal side effects.

Biotech firm Factor Bioscience has filed a lawsuit against Cellectis and AstraZeneca, accusing the companies of allegedly ...

GC Green Cross announced on September 4 that the results of its preclinical research on rare diseases, based on its independently developed LNP ...

Researchers have reconstructed transcription in human mitochondria in unprecedented detail, revealing potential drug targets ...

Aging, neurological diseases and our bodies' stress response are all linked to the tiny power plants inside each cell known as mitochondria. To ...